Toshiba America Medical Systems has received U.S. Food and Drug Administration (FDA) clearance for a new package of detector and software enhancements to its Aquilion One family of CT systems.
The version 7.0 package includes the following:
- AIDR 3D Enhanced, Toshiba's fourth-generation adaptive iterative dose reduction algorithm
- Its PureVision CT detector, with 40% better light output for improved use of x-ray photons
- SurekV automated kV selection based on patient size
- Organ effective modulation, which limits dose to radiosensitive organs and also during helical scanning and CT fluoroscopy procedures
- Contrast management features that improve workflow and safety by standardizing contrast protocols and automatically tracking volume of contrast used during an exam
- A power save mode that includes a sleep mode option for when the CT system is not in use
